Violeta Astratinei

@VAstratinei

Ph.D biologist and Patient Advocate

Netherlands/Romania
Vrijeme pridruživanja: listopad 2013.
41 fotografija ili videozapis Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @VAstratinei

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @VAstratinei

  1. proslijedio/la je Tweet
    4. velj

    Have your say! Especially all of us already affected by - we KNOW how our lives, values and priorities have changed. And how we had NO IDEA before- so if we do not share that insight, how will we build a better future for those who will be diagnosed with cancer tomorrow?

    join the consultation and have your say
    We have just launched an EU-wide public consultation on Europe's Beating Cancer Plan. The aim is for EU citizens and stakeholders to voice their opinion on the best ways to address this issue in the EU. More →
    Prikaži ovu nit
    5 proslijeđenih tweetova 11 korisnika označava da im se sviđa
    Poništi
  2. 2. velj

    Cool, deci avem precedent si experienta. Acum ar fi minunat sa avem date despre cum s-au desfasurat aceste programe din perspectiva pacientilor. Chestionare? Suntem deschisi la colaborare

    The dialysis programme and the radiotherapy programme for oncologic patients are covered by private health providers in a proportion of over 80%.
    Prikaži ovu nit
    Poništi
  3. 2. velj

    O combinatie de experti cu pretinsi experti, care ne dau analize bazate pe date trunchiate sau predictii tip oracol. Asta avem acum despre liberalizarea fondurilor din sanatate. Nu studii de impact, nu modele predictive, ci doar ’opinii avizate’🙄

    Poništi
  4. 2. velj

    Time to learn more about what is behind the early success of neoadjuvant therapy in melanoma! and we need

    There's so much more to learn about immunotherapy. Here's a new, outstanding review on checkpoint inhibitors as an adjunct to surgery by Suzanne Topalian, Janis Taube, w/
    3 proslijeđena tweeta 7 korisnika označava da im se sviđa
    Poništi
  5. 31. sij

    Actually, the interesting part here is the one about biomarkers and the implied call for better research

    1 proslijeđeni tweet
    Poništi
  6. proslijedio/la je Tweet
    31. sij

    Very detailed case report on first US case. Note nausea, vomiting, pcr+ loose stools, slow progression, and use of remdesivir.

    18 proslijeđenih tweetova 12 korisnika označava da im se sviđa
    Poništi
  7. 31. sij

    How patients are treated across Europe? We would like to hear about your country, please add your guideline!

    Thank you everyone who has helped so far- this is the collection of all guidelines we got so far: Anything missing or incorrect- please help us!
    1 reply 3 proslijeđena tweeta 4 korisnika označavaju da im se sviđa
    Poništi
  8. 30. sij

    We need better use of surgery for melanoma patients- respecting the last evidence is a good start!

    The role of radical surgical resection in advanced melanoma has become more conservative and cosmetically sensitive, according to Richard L. Shapiro, MD
    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  9. 30. sij

    The entire lot :-) was glad to learn about your work !

    Gilly, Bettina and Violeta: thank you for inviting me to the" WECAN Science" meeting. What a tremendous opportunity for me to share knowledge!
    2 proslijeđena tweeta 9 korisnika označava da im se sviđa
    Poništi
  10. 29. sij

    rare diseases remain, unfortunately, a challenge for both patients and research

    Knowledge is paramount to advance in research. But how do you map so scarce that it might affect just one person in the world? Welcome to the world of rare diseases:
    Poništi
  11. 29. sij

    In lipsa unui mecanism clar de evaluare a impactului schimbarilor din sanatate, trebuie sa fim de acord ca opinia expertului e mai buna decat diletantismul!

    Poništi
  12. proslijedio/la je Tweet
    23. stu 2019.

    The Economist despre cel mai prost sistem de sănătate din UE: „The culture of expediting care with petty bribes is notoriously hard to root out. Even more worrying,...

    4 proslijeđena tweeta 18 korisnika označava da im se sviđa
    Poništi
  13. 26. sij

    Meetings come to an end but the journey on the road of science just starts!

    3 korisnika označavaju da im se sviđa
    Poništi
  14. proslijedio/la je Tweet
    25. sij

    Huge huge shoutout to all of our colleagues at in Brussels‼️an amazing group of patient advocates with an amazing faculty, big 🚨shoutout to and our colleague ‼️ Best, &

    Great to have at talking with advocates representing so many different cancers across Europe.
    1 reply 6 proslijeđenih tweetova 20 korisnika označava da im se sviđa
    Poništi
  15. 25. sij

    Precision Medicine with , glad to have him at our first in Brussels!

    2 proslijeđena tweeta 9 korisnika označava da im se sviđa
    Poništi
  16. 24. sij

    Access for patients from Elsevier

    Poništi
  17. 24. sij

    The immunology lesson for cancer patient advocates by John Haanen!

    4 proslijeđena tweeta 9 korisnika označava da im se sviđa
    Poništi
  18. 24. sij

    The first day of our WECAN Science meeting in Brussels: why bother about science and what to expect!

    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
    Poništi
  19. proslijedio/la je Tweet
    19. pro 2019.

    we'd love to share your publication with our patient network as pathology reports remain a tricky topic (e.g. patients confounding Clark with Stage....), would you have an open author copy to share pls?

    3 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
    Poništi
  20. 14. lis 2019.

    Great opportunity to continue the excellent work of ! Thanks, everybody, and congratulations ! :-)

    Great news! has just been appointed as Chair! Thanks so much for taking on this important role for the European cancer patient community 🥳
    1 korisnik označava da mu se sviđa
    Poništi

@VAstratinei još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·